A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis

NCT00087529 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

439

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: placebo
DRUG: rituximab

Sponsor

Genentech, Inc.